NCT05306093已完成不适用
Chronic Effect of a Standardized Saffron Extract on Depressed Mood and Anhedonia in Healthy Adults. A Randomized Controlled Double-blind Clinical Trial.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 94
- 试验地点
- 2
- 主要终点
- Mood disturbance evaluated by the Profile Of Mood States (POMS) total score
研究概览
简要总结
The aim of this study is to evaluate the effect of nutraceutical supplement on depressed mood and anhedonia in volunteers after 8 weeks of consumption.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 20 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Adults aged between 20 and 65 years (limits included);
- •Body Mass Index (BMI) ≥19 and < 30 kg/m²;
- •Considered healthy based on their medical history and clinical examination;
- •Subjects self-reporting anhedonia based on SHAPS questionnaire. Score ≥ 3 allows the inclusion;
- •Subjects with depressive mood disturbance based on POMS depression subscale. Score ≥ 4 allows the inclusion;
- •Able and willing to participate to the study by complying with the protocol procedures as evidenced by his dated and signed informed consent form;
- •Affiliated with a social security scheme;
- •Agreeing to be registered on the national file of the volunteers in biomedical research.
排除标准
- •Suffer from mental health other than mild depressive or anxiety symptoms as measured by the Patient Health Questionnaire (PHQ-9). Volunteers with PHQ-9 score >14 could not be included;
- •Having suicidal thoughts: score ≥1 at the item 9 of the PHQ-9;
- •Diagnosis of medical or psychiatric conditions including (but not limited to):
- •psychiatric disorder (other than mild-to-moderate depression symptoms, anhedonia or anxiety),
- •neurological disease (Parkinson's, Alzheimer's disease, intracranial haemorrhage, head or brain injury),
- •cancer/malignancy,
- •cardiovascular disease (other than hypertension),
- •Immunological disease,
- •endocrine disease (including diabetes or thyroid diseases, Chronic kidney disease, hematological abnormalities);
- •Smokers (more than 5 cigarettes per day);
- •Uncontrolled hypertension with medication (SBP ≥ 160mmHg or DBP ≥ 100 mmHg) or without medication (SBP ≥ 140mmHg or DBP ≥ 90 mmHg);
- •Taking drugs (anxiolytics, antidepressants, antihistamine drug more than 7 day/month) known to have an impact on mental health in the month preceding inclusion and / or likely to consume them during the study and/or Illicit drug;
- •Undergoing a psychotherapy in the month preceding inclusion or during the study;
- •Consuming more than 3 standard drinks of alcoholic beverage daily;
- •Weight change above 10% body weight within the past 6 months before inclusion;
- •Currently under prescribed diet regimen, whatever the reason;
- •Consuming foods supplement known to have an influence on mental health in the month preceding the inclusion and / or likely to take during the study;
- •Consuming more than 50g of chocolate/day;
- •For females: Pregnant or planning pregnancy during the study or breastfeeding;
- •Any intolerance or allergy documented or suspected to one of the components of the study products;
- •Taking part in another clinical trial or being in the exclusion period of a previous clinical trial;
- •Subject who would receive more than 4500 euros as indemnities for his participation in biomedical research within the 12 last months, including the indemnities for the present study;
- •Under legal protection (guardianship, wardship) or deprived from his rights following administrative or judicial decision;
- •Presenting a psychological or linguistic incapability to sign the informed consent and to answer the study questionnaires
- •Any other condition which in the investigator's opinion may adversely affect the subject's ability to complete the study or its measures or which may pose significant risk to the subject.
结局指标
主要结局
Mood disturbance evaluated by the Profile Of Mood States (POMS) total score
时间窗: at 8 weeks (V3)
The POMS is a self-reported validated questionnaire assessing six mood subscales: tension-anxiety, depression, anger-hostility, vigor, fatigue, and confusion. In our study, a score on POMS depression subscale \< 4 does not allow the inclusion.
次要结局
- Depression level evaluated by the Center of Epidemiologic Studies Depression scale (CES-D) score(Baseline (V1) and each evaluation (at 1 week, 2 weeks, 3 weeks, 4 weeks (V2), 5 weeks, 6 weeks, 7 weeks and the end of the study : 8 weeks (V3)))
- Stress, spleep, anxiety, sadness, energy feeling, attention to others and desire to do things evaluated by Visual Analogic Scales (VAS) score(Baseline (V1) and each week evaluation (1 week, 2 weeks, 3 weeks, 4 weeks (V2), 5 weeks, 6 weeks, 7 weeks and the end of the study : 8 weeks (V3)))
- Quality of life evaluated by the Multicultural Quality of Life Index (MQLI)(Baseline (V1) and 1st month (4 weeks (V2)) and between baseline and the end of the study (8 weeks (V3)))
- Pleasure feeling evaluated by the Snaith-Hamilton Pleasure Scale (SHAPS) score(Baseline (V1) and each evaluation (2 weeks, 4 weeks (V2), 6 weeks and 8 weeks (V3))
- Tension, anger, vigour, fatigue and confusion evaluated by the five POMS sub-scores(Baseline (V1) and 1st month (4 weeks (V2)) and between baseline and the end of the study (8 weeks (V3)))
研究者
Jean-Michel Lecerf
Principal investigator
Institut Pasteur de Lille
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Effects of a Standardised Saffron Extract Supplementation on Symptoms Associated With Perimenopause in Healthy WomenPerimenopausal DisorderNCT06227858Liaquat University of Medical & Health Sciences104
尚未招募
4 期
Saffron as Anti Inflammatory In Patients With Inflammatory Bowel DiseaseUlcerative ColitisNCT05715099Minia University90
Unknown
不适用
Saffron as Anti Inflammatory Agent In Patients With Inflammatory Bowel DiseaseUlcerative ColitisNCT04749576Howard University100
招募中
不适用
Effect of Saffron Extract Supplementation on Emotional Well-being AlterationsMood DisturbanceNCT05690126Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement50
已完成
不适用
Effects of a saffron extract (affron) on mood, sleep, physical, and mental recovery in recreationally-active adults: a randomised, double-blind, placebo-controlled studyACTRN12621000501842Clinical Research Australia62